Vital Ksk Holdings
3151.TWholesale Trade
Financials · Consolidated
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥610.5bn | ¥600.4bn | ¥587.5bn | ¥581.3bnr | ¥578.8bnr | ¥538.5bnr |
| Operating income | ¥4.0bn | ¥5.7bn | ¥5.6bn | ¥4.0bnr | ¥2.9bn | −¥2.3bn |
| Ordinary income | ¥7.8bn | ¥7.0bn | ¥6.6bn | ¥6.0bn | ¥5.8bn | ¥693m |
| Net income (owners) | ¥7.4bn | ¥7.3bn | ¥5.8bn | ¥4.8bn | ¥4.8bn | ¥1.2bn |
| Total assets | ¥320.6bn | ¥299.4bn | ¥317.3bn | ¥297.3bn | ¥313.0bn | ¥311.4bn |
| Net assets / equity | ¥118.7bn | ¥107.3bn | ¥105.9bn | ¥100.2bn | ¥100.0bn | ¥103.9bn |
| Operating cash flow | ¥4.8bn | −¥8.0bn | ¥23.6bn | −¥3.0bn | ¥7.5bn | −¥1.4bn |
| EPS (basic) | ¥152.29 | ¥149.02 | ¥115.03 | ¥92.69 | ¥87.88 | ¥21.26 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 2
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2025-09-30 | Half-year | 71 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 71 figures · EDINET |
21 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| Medicine Wholesale | ¥572.9bn | ¥4.9bn |
| Nursing Care Related Rental And Other Business | ¥5.0bn | −¥102m |
| Pharmaceutical Business | — | −¥1.3bn |
| Pharmacy Business | ¥20.0bn | ¥252m |
| Veterinary Drugs Wholesale Business | ¥12.6bn | ¥304m |
| Adjustments & eliminations | — | −¥35m |
| Total | ¥610.5bn | ¥4.1bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.